Analysts expect Human Genome Sciences Inc. (Nasdaq: HGSI) to report disappointing results from its lupus drug trial on Monday but speculators sent the stock price soaring 60 cents to close at $3.35.
Human Genome Soars
July 16, 2009 at 21:42 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.